Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
BMC Neurol ; 21(1): 113, 2021 Mar 12.
Article in English | MEDLINE | ID: mdl-33711950

ABSTRACT

BACKGROUND: Removal of large hypervascular tumors in the lateral ventricle still poses a surgical challenge. These tumors are usually fed from choroidal arteries, and vascular control is typically performed late during the removal. We aimed to evaluate the clinical efficacy of our strategy for persistent preoperative obliteration of feeders from the choroidal arteries to manage large hypervascular tumors in the lateral ventricle. METHODS: We retrospectively analyzed six patients with hypervascular tumors in the lateral ventricle. We first attempted to obstruct feeders using endovascular treatment, and, if unavailable, performed initial microsurgical occlusion through the temporal horn for the staged tumor removal. RESULTS: In all patients, feeder obliteration was successfully performed; the anterior choroidal arteries were occluded by the endovascular treatment and microsurgical occlusion in one and five patients, respectively, while the lateral posterior choroidal arteries were occluded via endovascular treatment in four patients. No patients had permanent symptoms due to feeder obliteration, and tumor devascularization was achieved at the mean rate of 69.9%. During the tumor removal, the mean blood loss volume was 253 ml. No postoperative hemorrhage had occurred, and all patients scored ≤ 2 on the modified Rankin Scale at six months post-removal. CONCLUSIONS: Although further studies are warranted, persistent feeder obliteration of choroidal arteries could be an effective treatment strategy against large hypervascular tumors in the lateral ventricle.


Subject(s)
Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/therapy , Embolization, Therapeutic/methods , Adult , Aged , Cerebral Arteries/surgery , Endovascular Procedures/methods , Female , Humans , Lateral Ventricles/pathology , Lateral Ventricles/surgery , Male , Middle Aged , Retrospective Studies , Treatment Outcome
2.
Brain Tumor Pathol ; 32(2): 124-30, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24984922

ABSTRACT

BACKGROUND: The rosette-forming glioneuronal tumour (RGNT) is a rarely encountered tumour that has been included as a new entity in the 2007 edition of the "World Health Organization (WHO) Classification of Tumours of the Central Nervous System". We describe a rather unusual case of multifocal cerebellar RGNT, located in the spinal cord and displaying leptomeningeal spread. CLINICAL PRESENTATION: Twenty-four-year-old male with history of long-lasting headaches. A magnetic resonance scan revealed three heterogeneous lesions located within both cerebellar hemispheres and the left cerebellopontine angle, in addition to a spinal cord lesion at the level of the cervical region, and images of leptomeningeal spread. Interventions were performed in two stages; these involved resection of two cerebellar lesions, with a histopathological diagnosis of RGNT with atypical microvascular proliferation and focal necrosis. Although these tumours appear to be benign, our case debuted in an aggressive form, both from the radiological point of view and with respect to its histopathological characteristics. For this reason, the patient received adjuvant therapy with chemotherapy and radiotherapy. CONCLUSIONS: Experience of RGNT is limited. The prognostic significance of the histological findings of vascular proliferation and necrosis is still unknown. The clinical improvement in our patient endorses our decision to perform aggressive treatment.


Subject(s)
Cerebral Ventricle Neoplasms/pathology , Fourth Ventricle/pathology , Glioma/pathology , Neuroma/pathology , Spinal Cord Neoplasms/pathology , Spinal Cord/pathology , Adult , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/therapy , Combined Modality Therapy , Diagnostic Imaging , Disease Progression , Glioma/blood supply , Glioma/therapy , Humans , Male , Microvessels/pathology , Necrosis , Neoplasm Invasiveness , Neuroma/blood supply , Neuroma/therapy , Spinal Cord Neoplasms/blood supply , Spinal Cord Neoplasms/therapy , Treatment Outcome , Young Adult
3.
Acta Neurochir (Wien) ; 156(4): 681-7, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24445733

ABSTRACT

BACKGROUND: Narrow-band imaging (NBI) has been confirmed as a useful endoscopic technique to distinguish neoplasm from normal tissue, on the basis of the enhanced neovascularity of tumor tissue. NBI-guided tissue biopsy for laryngopharyngeal and digestive lesions is a novel methodology, but the feasibility for central nervous system tumors remains unclear. The aim of our study was to evaluate the feasibility of NBI-guided biopsy for intraventricular and paraventricular tumor. METHODS: Fourteen patients with intraventricular or paraventricular tumors underwent neuroendoscopic biopsy using a videoscope with NBI. Ventricular walls and tumors were observed using conventional imaging, followed by NBI. Colors of ventricle walls and tumors visualized using NBI were compared to those visualized under conventional imaging. Extracted specimens were stained using CD31 antibody and numbers of microvessels in each specimen were counted for analyzing vascular density. RESULTS: Normal ventricle walls were a similar color under conventional imaging and NBI. Tumor surfaces appeared to be cyan in color under NBI. Vessels on the tumor were more clearly visualized with NBI than with conventional imaging. NBI was able to identify tumor surfaces that were not perceptible on conventional imaging. All specimens in the lesion surfaces from cyan-colored areas under NBI contained tumor cells. Specimens extracted from regions that appeared cyan in color under NBI (51.0 vessels/mm(2)) had significantly greater vascular density than regions that appeared a normal color (17.4 vessels/mm(2); p = 0.039). CONCLUSION: NBI-guided biopsy of intraventricular and paraventricular tumors is feasible for visualizing tumor surface-enhancing neovascularities. NBI would contribute to accurate histological diagnosis while minimizing injury to surrounding structures.


Subject(s)
Brain Neoplasms/pathology , Cerebral Ventricle Neoplasms/pathology , Endoscopy/methods , Narrow Band Imaging/methods , Neurosurgical Procedures/methods , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy , Brain Neoplasms/blood supply , Cerebral Ventricle Neoplasms/blood supply , Child , Feasibility Studies , Female , Humans , Male , Microvessels/pathology , Middle Aged , Neovascularization, Pathologic/pathology , Retrospective Studies , Surgery, Computer-Assisted/methods , Young Adult
4.
Cancer Chemother Pharmacol ; 72(1): 93-100, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23649683

ABSTRACT

BACKGROUND: Combining anti-angiogenesis agents with cytotoxic agents for the treatment of malignant gliomas may affect the cytotoxic drug distribution by normalizing the blood-brain barrier (BBB). This study examines the intratumoral concentration of temozolomide (TMZ) in the presence and absence of the pan-VEGF receptor tyrosine kinase inhibitor, cediranib. METHODS: Seven nude rats bearing U87 intracerebral gliomas had a microdialysis probe centered within the tumor. Ten-days after tumor implantation, TMZ (50 mg/kg) was given orally. The extracellular fluid (ECF) concentrations of TMZ within the tumor were assessed via microdialysis for 6 h following TMZ administration. Cediranib (6 mg/kg) was then given orally, and 12 h later, TMZ was re-administered with subsequent microdialysis collection. A subset of animals also underwent functional MRI to assess angiogenesis in vivo at post-inoculation days 12 and 21, before and after the cediranib treatment. RESULTS: After dosing of oral TMZ only, ECF-TMZ mean-C(max) and area under the concentration curve(AUC(0-∞)) within the tumor were 0.59 µg/mL and 1.82 µg h/mL, respectively. Post-cediranib, ECF-TMZ mean-C(max) and AUC(0-∞) were 0.83 µg/mL and 3.72 ± 0.61 µg h/mL within the tumor, respectively. This represented a 1.4-fold (p = 0.3) and 2.0-fold (p = 0.06) increase in the ECF-TMZ C(max) and AUC(0-∞), respectively, after cediranib administration. In vivo MRI measurements of the various vascular parameters were consistent with a BBB "normalization" profile following cediranib treatment. CONCLUSIONS: In the U87 intracerebral glioma model, within the first day of administration of cediranib, the intratumoral concentrations of TMZ in tumor ECF were slightly, but not statistically significantly, increased when compared to the treatment of TMZ alone with radiographic evidence of a normalized BBB.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics , Blood-Brain Barrier/drug effects , Cerebral Ventricle Neoplasms/drug therapy , Dacarbazine/analogs & derivatives , Glioma/drug therapy , Quinazolines/therapeutic use , Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/therapeutic use , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Antineoplastic Agents, Alkylating/administration & dosage , Antineoplastic Agents, Alkylating/metabolism , Antineoplastic Agents, Alkylating/pharmacokinetics , Antineoplastic Agents, Alkylating/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/metabolism , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/metabolism , Cerebral Ventricles/drug effects , Cerebral Ventricles/metabolism , Dacarbazine/administration & dosage , Dacarbazine/metabolism , Dacarbazine/pharmacokinetics , Dacarbazine/therapeutic use , Drug Synergism , Extracellular Fluid/drug effects , Extracellular Fluid/metabolism , Glioma/blood supply , Glioma/metabolism , Humans , Male , Microdialysis , Neovascularization, Pathologic/prevention & control , Protein Kinase Inhibitors/administration & dosage , Protein Kinase Inhibitors/therapeutic use , Quinazolines/administration & dosage , Rats , Rats, Nude , Temozolomide , Xenograft Model Antitumor Assays
5.
World Neurosurg ; 78(1-2): 191.E9-14, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22120386

ABSTRACT

BACKGROUND: The progression of laser technology in neurosurgery has been limited by the poor maneuverability of traditional line-of-sight carbon dioxide (CO2) lasers and the propensity of other laser energies to cause collateral thermal injury to adjacent neural structures. The advent of a dielectric omnidirectional reflector and the subsequent development of phototonic bandgap fibers (PBF) have transformed the CO2 laser into a low-profile instrument with considerable dexterity and many potential new neurosurgical applications. CASE DESCRIPTION: A 48-year-old woman presented with a large mass in the left lateral ventricle that was first diagnosed>20 years ago. The patient was asymptomatic until 1 month before presentation, when she began to experience progressive memory loss and neurocognitive decline. RESULTS: The hand-held CO2 laser was used to debulk the tumor. The CO2 laser vaporized neoplastic cellular material and simultaneously cauterized microvascular structures. CONCLUSIONS: The CO2 laser was exceptionally useful in the resection of this long-standing and extremely calcified, yet vascular mass. A review of the evolution of laser technology applications in neurosurgery is presented, with a specific focus on the innovations that led to the development of the new PBF CO2 laser. This new technology may be advantageous in tumor surgery, particularly in the resection of long-standing calcified and vascular tumors that are not amendable to traditional surgical techniques.


Subject(s)
Calcinosis/surgery , Cerebral Ventricle Neoplasms/surgery , Laser Therapy/instrumentation , Lasers, Gas , Lateral Ventricles/surgery , Neovascularization, Pathologic/surgery , Papilloma, Choroid Plexus/surgery , Calcinosis/diagnosis , Calcinosis/pathology , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/diagnosis , Cerebral Ventricle Neoplasms/pathology , Equipment Design , Follow-Up Studies , Humans , Lateral Ventricles/blood supply , Lateral Ventricles/pathology , Male , Middle Aged , Neovascularization, Pathologic/diagnosis , Neovascularization, Pathologic/pathology , Neurologic Examination , Papilloma, Choroid Plexus/blood supply , Papilloma, Choroid Plexus/pathology , Postoperative Complications/diagnosis , Tomography, X-Ray Computed
6.
Neurochirurgie ; 57(4-6): 161-9, 2011.
Article in French | MEDLINE | ID: mdl-22036149

ABSTRACT

The lateral ventricle is a deep-seated cavity, overlayed by a cortical mantle which contains eloquent areas, especially on the dominant hemisphere, and surrounded by the optic radiations. The surgical approach requires a thorough preoperative reflexion based on magnetic resonance imaging, in order to understand the site of origin and the vascular pedicles of the tumor. Surgical approaches to the frontal horn, temporal horn and atrium are successively described.


Subject(s)
Lateral Ventricles/anatomy & histology , Lateral Ventricles/surgery , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/complications , Cerebral Ventricle Neoplasms/pathology , Cerebral Ventricle Neoplasms/surgery , Functional Laterality , Humans , Hydrocephalus/etiology , Hydrocephalus/surgery , Magnetic Resonance Imaging , Neurosurgical Procedures/methods , Regional Blood Flow/physiology , Sphenoid Sinus/surgery
7.
Neurochirurgie ; 57(4-6): 156-60, 2011.
Article in French | MEDLINE | ID: mdl-22030174

ABSTRACT

Tumors of the frontal horn of the lateral ventricle (LV) are only supplied by the posteromedial choroidal artery. Tumors of the body of the LV are supplied by the same artery. Tumors of the atrium of the LV with anterior extension are supplied by both posteromedial choroidal and posterolateral arteries. Tumors of the atrium with inferior extension are supplied by both anterior choroidal artery and posterolateral choroidal arteries. Tumors of the inferior horn are only supplied by anterior choroidal artery. The tumoral venous drainage is organized with three main groups of veins: a medial group, a lateral group and a choroidal group.


Subject(s)
Cerebral Arteries/physiology , Cerebral Veins/physiology , Lateral Ventricles/blood supply , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/pathology , Cerebrovascular Circulation/physiology , Choroid Plexus/blood supply , Choroid Plexus Neoplasms/blood supply , Choroid Plexus Neoplasms/pathology , Choroid Plexus Neoplasms/secondary , Humans , Magnetic Resonance Imaging
8.
Brain Pathol ; 20(1): 257-60, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20438485

ABSTRACT

Intracranial capillary hemangiomas are extremely rare. Only 14 histologically proven cases have been reported in the literature. A 59-year-old-female presented with a severe headache for 3 weeks. Brain MRI revealed a homogeneous contrast enhancing round mass lesion in the pituitary stalk and infundibular recess. We performed endoscopic biopsy. In the operative field, a reddish, well-circumscribed mass from the infundibular recess protruded into the third ventricle and it was separated from the optic chiasm. The tumor appeared a highly vascular. Histopathological examination demonstrated an aggregation of thin-walled capillaries, consistent with capillary hemangioma.


Subject(s)
Cerebral Ventricle Neoplasms/pathology , Hemangioma, Capillary/pathology , Pituitary Neoplasms/pathology , Biopsy , Cerebral Ventricle Neoplasms/blood supply , Endoscopy , Female , Hemangioma, Capillary/blood supply , Humans , Magnetic Resonance Imaging , Middle Aged , Optic Chiasm/blood supply , Optic Chiasm/pathology , Pituitary Gland/pathology , Pituitary Neoplasms/blood supply , Regional Blood Flow/physiology , Third Ventricle/pathology
9.
Neurol Med Chir (Tokyo) ; 50(2): 139-43, 2010.
Article in English | MEDLINE | ID: mdl-20185880

ABSTRACT

A 21-year-old man presented with a hemorrhagic central neurocytoma manifesting as acute onset of disturbance of consciousness and right hemiparesis. Computed tomography (CT) demonstrated a tumor in the left lateral ventricle during the course of evaluation for mental alteration 12 days before onset, but the tumor was left untreated because the patient refused to visit a neurosurgical institution. CT on admission revealed a large mass lesion located in the body of the lateral ventricle associated with massive intratumoral and intraventricular hemorrhage. He underwent emergent surgery for evacuation of the tumor with hematoma, and his neurological symptoms gradually recovered after surgery. The present case highlights the possibility of rapid deterioration of symptoms by massive hemorrhage from central neurocytoma. Surgical intervention should thoroughly be considered, if intratumoral hemorrhage is present, as hemorrhage from the central neurocytoma may lead to serious neurological complications.


Subject(s)
Cerebral Hemorrhage/pathology , Cerebral Ventricle Neoplasms/pathology , Coma/etiology , Lateral Ventricles/pathology , Neurocytoma/pathology , Biomarkers, Tumor/analysis , Brain/blood supply , Brain/diagnostic imaging , Brain/pathology , Cerebral Hemorrhage/etiology , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/complications , Disease Progression , Emergency Medical Services/methods , Emergency Medical Services/standards , Humans , Lateral Ventricles/blood supply , Lateral Ventricles/diagnostic imaging , Male , Neurocytoma/blood supply , Neurocytoma/complications , Neurosurgical Procedures , Paresis/etiology , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , Ventriculostomy , Young Adult
10.
Acta Neurochir (Wien) ; 151(12): 1717-21, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19387539

ABSTRACT

OBJECTIVE: The optimal surgical approach for a trigone meningioma is still controversial. Here, we report two patients with trigone meningioma treated successfully via an occipital inter-hemispheric and trans-cortical approach in the lateral semi-prone position. CLINICAL PRESENTATION: A 53-year-old woman was admitted to a local hospital with sudden transient dizziness and vomiting. The CT brain scan demonstrated a right intra-ventricular tumour. She was therefore transferred to our hospital for surgical treatment. The other patient was a 67-year-old woman who was admitted to a local hospital after a traffic accident and a CT brain scan revealed an incidental right intra-ventricular tumour. After referral to our hospital, periodic MRI examinations revealed gradual tumour enlargement within a one-year period. Neither of the patients had any neurological deficits, including in the visual fields. INTERVENTION: The head of each patient was positioned so that the tumour-containing right ventricle was oriented downwards and laterally. An occipital inter-hemispheric approach was performed and using a navigation system, the tumour was identified about 1 cm in depth from the cortical surface. After the medial part of the tumour was debulked, the posterior and then the anterior choroidal blood supplies to the tumour were identified. Occlusion of these vessels achieved tumour haemostasis. The tumours were totally removed via a 1.5-cm cortical incision. Brain retraction was minimal because the right hemisphere was pulled down by gravity. Therefore, the para-splenial cisterns were easily accessed, resulting in early release of cerebrospinal fluid. Post-operative MRI showed complete removal of the tumour and the patients had no neurological deficits. Anti-epileptic medication was withdrawn one week after the operation. CONCLUSIONS: The occipital inter-hemispheric fissure lacks important bridging veins. The approach used and patient positioning minimized damage to the lateral aspect of the optic radiation and the corpus callosum. Except in patients with very large trigone meningiomas, this approach is useful for decreasing the risk of post-operative hemianopsia or epilepsy, and possibly speech disturbance, even in patients with a tumour in the dominant hemisphere.


Subject(s)
Cerebral Ventricle Neoplasms/pathology , Cerebral Ventricle Neoplasms/surgery , Lateral Ventricles/pathology , Lateral Ventricles/surgery , Meningioma/pathology , Meningioma/surgery , Aged , Cerebral Ventricle Neoplasms/blood supply , Female , Humans , Meningioma/blood supply , Middle Aged , Neurosurgical Procedures/methods , Occipital Lobe/anatomy & histology , Occipital Lobe/surgery , Treatment Outcome
11.
Neuropathology ; 29(1): 85-90, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18498285

ABSTRACT

Chordoid glioma, which generally occurs in adults, is a rare CNS tumor arising in the anterior part of the third ventricle. We report two cases of chordoid glioma of the third ventricle in a 42-year-old woman and a 51-year-old man, respectively. Both tumors showed essentially the same histological and immunohistochemical features; the tumors were composed of cords and nests of epithelioid, GFAP-immunoreactive cells in a mucinous stroma with lymphoplasmacytic infiltrates at the tumor periphery. Ultrastructural examination in one case revealed that the tumor cells were characterized by the presence of hemidesmosomes and associated focal basal lamina formation, intermediate junctions, microvilli and cilia, and intercellular microrosettes with microvilli. Of interest was that small blood vessels with fenestrated endothelial cells were present in the stroma. In the brain, the presence of fenestrated endothelial cells is a feature of the circumventricular organs (except the subcommissural organ), among which the organum vasculosum of the lamina terminalis is located in the anterior part of the third ventricular floor that is lined by specialized ependymal cells known as tanycytes. These findings further strengthen the hypothesis that chordoid glioma may represent a peculiar clinicopathological subtype of ependymoma (chordoid ependymoma) originating from the lamina terminalis area.


Subject(s)
Cerebral Ventricle Neoplasms/pathology , Glioma/pathology , Third Ventricle , Adult , Basement Membrane/pathology , Blood Vessels/pathology , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/chemistry , Cerebral Ventricle Neoplasms/ultrastructure , Cilia/pathology , Endothelial Cells/pathology , Ependymoma/pathology , Epithelioid Cells/pathology , Female , Glial Fibrillary Acidic Protein/analysis , Glioma/blood supply , Glioma/chemistry , Glioma/ultrastructure , Hemidesmosomes/pathology , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Male , Microscopy, Electron , Microvilli/pathology , Middle Aged , Tomography, X-Ray Computed
13.
J Comput Assist Tomogr ; 31(6): 896-900, 2007.
Article in English | MEDLINE | ID: mdl-18043353

ABSTRACT

In this report, we separately performed dynamic computed tomographic perfusion and dynamic susceptibility contrast-T2 magnetic resonance perfusion imaging on 2 cases of brain tumors (one was a glioblastoma, and the other was a central neurocytoma). Between the 2 methods, we saw the discrepancy in values of cerebral blood volume and cerebral blood flow, differences in location of the maximal cerebral blood volume, and regions with abnormal increased cerebral blood flow besides the solid part of the tumors. Both differences and similarities of the 2 techniques with their advantages and pitfalls were analyzed in detail. The developing trends in the near future were also discussed.


Subject(s)
Brain Neoplasms/blood supply , Image Enhancement/methods , Magnetic Resonance Imaging/methods , Radiographic Image Enhancement/methods , Tomography, X-Ray Computed/methods , Adult , Blood Volume/physiology , Brain Neoplasms/diagnosis , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/diagnosis , Cerebrovascular Circulation/physiology , Contrast Media , Echo-Planar Imaging/methods , Frontal Lobe/blood supply , Gadolinium DTPA , Glioblastoma/blood supply , Glioblastoma/diagnosis , Humans , Iohexol , Male , Middle Aged , Neurocytoma/blood supply , Neurocytoma/diagnosis , Temporal Lobe/blood supply
14.
Clin Neurol Neurosurg ; 109(10): 884-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17764829

ABSTRACT

Only a few cases of intraventricular meningioma have been reported and the association with intracranial haemorrhage is even rarer. More than ever, autopsy findings are scarce. Here, we report a case of primary intraventricular meningioma with intraventricular haemorrhage in a 57-year-old woman. A CT scan of the head initially suggested a malignant brain tumour as the lesion was quite inhomogeneous with hyper- and hypodense sections accompanied by fresh haemorrhage. At autopsy, the tumour was histologically diagnosed as a fibroblastic meningioma WHO-Grade I. The source of haemorrhage was most likely the tumour itself as it contained focally rather large angiomatous and additionally small cavernous vessels and acute haemorrhage in various sections. The assumptive adherence of the tumour to the choroid plexus was probably disrupted by the haematoma.


Subject(s)
Cerebral Hemorrhage/pathology , Cerebral Ventricle Neoplasms/pathology , Meningeal Neoplasms/pathology , Meningioma/pathology , Brain/pathology , Brain Edema/pathology , Cerebral Ventricle Neoplasms/blood supply , Fatal Outcome , Female , Glasgow Coma Scale , Humans , Hydrocephalus/pathology , Lateral Ventricles/blood supply , Lateral Ventricles/pathology , Meningeal Neoplasms/blood supply , Meningioma/blood supply , Middle Aged , Neovascularization, Pathologic/pathology , Tomography, X-Ray Computed
15.
AJNR Am J Neuroradiol ; 24(10): 1999-2004, 2003.
Article in English | MEDLINE | ID: mdl-14625222

ABSTRACT

We report five cases of tumors occurring in three children and in two adults. The tumors had unusual histomorphology and a mixture of ependymal and piloid-like astrocytic features and a myxoid stroma similar to myxopapillary ependymomas. MR imaging in three of the cases showed aggressive, intensely enhancing partially cystic hypothalamic-suprasellar masses near midline and near the floor of the third ventricle. In the three pediatric cases, the tumor encased the circle of Willis. This newly characterized tumor, the tanycytoma, has neoplastic cells with histomorphologic and ultrastructural characteristics similar to those of the tanycyte.


Subject(s)
Cerebral Ventricle Neoplasms/pathology , Hypothalamic Neoplasms/pathology , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Adult , Astrocytoma/pathology , Cerebral Ventricle Neoplasms/blood supply , Child, Preschool , Circle of Willis/pathology , Ependyma/pathology , Ependymoma/pathology , Female , Humans , Hypothalamic Neoplasms/blood supply , Male , Middle Aged , Sella Turcica
16.
Neuroradiology ; 44(10): 842-6, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12389135

ABSTRACT

Chordoid glioma is a homogeneous tumour involving the third ventricular region of middle-aged women, containing a small central cyst or necrosis. Histologically the tumour has a chordoid appearance. We report a new case with a haemodynamic imaging approach which indicates tumour angiogenesis at the capillary level.


Subject(s)
Cerebral Ventricle Neoplasms/diagnosis , Glioma/diagnosis , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Adult , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricles/pathology , Female , Glioma/blood supply , Humans
17.
J Neuropathol Exp Neurol ; 56(5): 551-6, 1997 May.
Article in English | MEDLINE | ID: mdl-9143268

ABSTRACT

The proliferative potential of central neurocytomas was determined in a biopsy series of 36 cases and compared with clinical outcome. The mean size of the growth fraction, as determined by MIB-1 labeling index (MIB-1 LI) at first biopsy, was 2.8 +/- 2.5 with a range of 0.1 to 8.6%. Neurocytomas with an MIB-1 LI > 2% comprised 39% of cases and showed a close correlation with the presence of vascular proliferation (p = 0.0006). The Kaplan-Meier analysis showed a highly significant difference in disease-free survival between the 2 groups (p = 0.0068). Over an observation time of 150 months, there was a 22% relapse among patients with an MIB-1 LI less than 2% and a 63% chance of relapse among those with an MIB-1 LI greater than 2%. We propose the term "atypical central neurocytoma" for the latter subset, corresponding to WHO grade II.


Subject(s)
Cerebral Ventricle Neoplasms/pathology , Neurocytoma/pathology , Adolescent , Adult , Biopsy , Cerebral Ventricle Neoplasms/blood supply , Cerebral Ventricle Neoplasms/metabolism , Child , Female , Humans , Immunohistochemistry , Male , Middle Aged , Neoplasm Recurrence, Local , Neovascularization, Pathologic/pathology , Neurocytoma/blood supply , Neurocytoma/metabolism , Survival Analysis
18.
Brain Tumor Pathol ; 14(1): 79-83, 1997.
Article in English | MEDLINE | ID: mdl-9384808

ABSTRACT

A case of central neurocytoma that was confirmed with ultrastructural and immunohistochemical studies has been reported. Ultrastructurally, thin cytoplasmic processes of tumor cells showed differentiation into neuronal cells containing parallel bundles of microtubules and abortive synapses with dense-core vesicles and/or clear vesicles. It was frequently found that the clusters of tumor cell processes were close to or around the microvessels. Microvessels were composed of endothelial cells without fenestrations and had tight junctions in the endothelial clefts. Neurosecretory granules in thin cell processes appeared close to microvessels and may have been secreted around microvessels.


Subject(s)
Cerebral Ventricle Neoplasms/blood supply , Neurocytoma/blood supply , Neurocytoma/ultrastructure , Adult , Biomarkers/analysis , Cerebral Ventricle Neoplasms/chemistry , Cerebral Ventricle Neoplasms/pathology , Glial Fibrillary Acidic Protein/analysis , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Male , Microcirculation/chemistry , Microcirculation/pathology , Microcirculation/ultrastructure , Neurocytoma/chemistry , Neurocytoma/pathology , Synaptophysin/analysis
19.
No Shinkei Geka ; 24(3): 211-9, 1996 Mar.
Article in Japanese | MEDLINE | ID: mdl-8851949

ABSTRACT

To estimate hemocirculation and proliferating activity of intraventricular tumor, we measured kinetic rate constants (k1, k2, k3) and glucose metabolic rate (kinetic-rCMRGl) using dynamic positron emission tomography (PET), as well as regional cerebral blood flow (rCBF), blood volume (rCBV), oxygen extraction fraction (rOEF), oxygen metabolic rate (rCMRO2) and autoradiographic rCMRGl (arg-rCMRGl), in patients with intraventricular tumor. The subjects included ten patients, five males and five females, aged from 13 to 53 years with a mean age of 32 years old. Eight tumors were located in the lateral ventricle and two extended into the third ventricle through the foramen of Monro. Another two tumors were located in the fourth ventricle. Histological diagnosis was as follows: five cases of central neurocytoma, one subependymal giant cell astrocytoma, one ependymoma, one choroid plexus carcinoma, one subependymoma, and one meningioma. Tumor lesion on the PET images was determined using CT or MRI, which was performed at levels equivalent to those for the PET scans. For quantitative analysis, regions of interest (ROI) on PET images were delineated on the tumor and the contralateral gray matter. Hemocirculation (rCBF, rCBV) of the tumor was similar to or higher than that of the contralateral gray matter, which corresponded to neuroradiological findings of abundant tumor vessels. Oxygen metabolic parameters (rOEF, rCMRO2) were significantly lower than those of the contralateral gray matter. Especially, low rOEF resulted in an excessive blood flow beyond oxygen demand of the tumor. The raised metabolic rate (rCMRO2/rCMRGl), as compared with that of meningiomas or malignant gliomas, suggested aerobic glycolysis. The kinetic rate constants of tracer transport from blood to brain (k1), reverse transport from brain to blood (k2), and phosphorylation (k3) were analyzed according to the three-compartment model of 18F-fluorodeoxyglucose (18FDG). Tumor k1 and k2 values were similar to or higher than those of the contralateral gray matter, suggesting high permeability due to lack of blood-brain barrier and an abundant blood supply. Tumor k3 value, an indicator of hexokinase activity, and kinetic-rCMRGl were lower in six of eight patients. These six patients have been free from tumor recurrence or regrowth, postoperatively. In the other two patients, tumor kinetic-rCMRGl was similar to or higher than that of the contralateral gray matter, suggesting high activity of proliferation. However, one patient received irradiation and has been followed up, and the other received total resection and has shown no recurrence. Functional information concerning intraventricular tumor is obtained by PET analysis, and kinetic analysis of the rate constants is useful for interpreting a detailed metabolic process of glucose, and provides additional information on intraventricular tumor aggressiveness.


Subject(s)
Cerebral Ventricle Neoplasms/metabolism , Cerebrovascular Circulation , Glucose/metabolism , Adolescent , Adult , Blood Volume , Capillary Permeability , Cerebral Ventricle Neoplasms/blood supply , Deoxyglucose/analogs & derivatives , Female , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Kinetics , Male , Middle Aged , Oxygen/metabolism , Tomography, Emission-Computed
20.
Cancer ; 76(7): 1224-32, 1995 Oct 01.
Article in English | MEDLINE | ID: mdl-8630902

ABSTRACT

BACKGROUND: New World Health Organization classifications have categorized central neurocytomas as neuronal tumors. The differential diagnosis between central neurocytomas and other tumors is important for selection of the optimal therapy modality for the management of intraventricular tumors. To characterize the pathophysiology and proliferating activity of central neurocytoma accurately, cerebral blood flow and metabolism in five patients with central neurocytoma were studied using positron emission tomography (PET). METHODS: Tracers used for the present study included C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG). Regional cerebral blood flow (rCBF), cerebral blood volume (rCBV), oxygen extraction fraction (rOEF), cerebral metabolic rate of oxygen (rCMRO2), and cerebral metabolic rate of glucose (rCMRGl) were quantitatively analyzed in tumor lesions and the contralateral gray matter. Four patients with central neurocytoma underwent a complete PET study, including all circulatory and metabolic parameters; one patient was studied with 11C-methyl-L-methionine and FDG tracers. RESULTS: Tumor rCBF and rCBV were higher than comparable values in the contralateral gray matter in three of four patients. This high level of perfusion corresponds to angiographic findings that show intense tumor staining in tumors fed by perforated arteries. Tumor rOEF and rCMRO2 were significantly lower than corresponding values in the gray matter (rOEF, P < 0.01; rCMRO2, P < 0.05 by Student's t test). Tumor rCMRGl ranged from 2.68 to 6.26 mg/100 ml/minutes and did not exceed contralateral gray matter values in any of the five patients. Tumor rCMRGl was significantly lower (P < 0.02) than the gray matter rCMRGl. One tumor exhibited a relatively high value of rCMRGl (comparable to gray matter rCMRGl), and increased in size 4 months after partial resection. No other tumors appeared during postoperative follow-up periods that ranged from 4 to 135 months. CONCLUSIONS: Circulation and metabolism parameters measured by PET offer insight into the biologic characteristics of central neurocytoma. Tumor rCMRGl may be an indicator of the proliferating activity in central neurocytoma.


Subject(s)
Cerebral Ventricle Neoplasms/blood supply , Cerebrovascular Circulation , Neurocytoma/blood supply , Tomography, Emission-Computed , Adult , Blood Volume , Carbon Radioisotopes , Cerebral Ventricle Neoplasms/diagnostic imaging , Cerebral Ventricle Neoplasms/metabolism , Deoxyglucose/analogs & derivatives , Female , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Glucose/metabolism , Humans , Male , Methionine/analogs & derivatives , Middle Aged , Neurocytoma/diagnostic imaging , Neurocytoma/metabolism , Oxygen/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...